PRESS RELEASE published on 10/14/2025 at 07:00, 9 months ago Inside Information / Other news releases Innate Pharma to host analyst and investor event on Lacutamab on October 28, 2025. Event includes clinical perspectives, market outlook, and updates on Phase 3 trial and regulatory pathway for lacutamab Phase 3 Trial Investor Event Regulatory Pathway Innate Pharma Lacutamab
PRESS RELEASE published on 10/14/2025 at 07:00, 9 months ago Informations privilégiées / Autres communiqués Innate Pharma organise un événement analystes et investisseurs dédié à Lacutamab le 28 octobre 2025, mettant en lumière les perspectives cliniques et commerciales du produit Investisseurs Événement Innate Pharma Analystes Lacutamab
PRESS RELEASE published on 09/22/2025 at 13:41, 9 months 21 days ago Informations privilégiées / Communiqué sur comptes, résultats
PRESS RELEASE published on 09/17/2025 at 07:00, 9 months 27 days ago Informations privilégiées / Communiqué sur comptes, résultats
BRIEF published on 09/10/2025 at 10:35, 10 months 3 days ago Innate Pharma Annonce une Conférence Téléphonique pour ses Résultats Semestriels 2025 Résultats Financiers Immunothérapie Conférence Téléphonique Partenariats Biopharmaceutiques Innate Pharma
BRIEF published on 09/10/2025 at 10:35, 10 months 3 days ago Innate Pharma Announces 2025 Half-Year Results Conference Call Financial Results Conference Call Immunotherapy Innate Pharma Biopharmaceutical Partnerships
PRESS RELEASE published on 09/10/2025 at 10:30, 10 months 3 days ago Informations privilégiées / Autres communiqués Innate Pharma organise une conférence téléphonique pour présenter ses résultats financiers et l’avancée de son portefeuille au premier semestre 2025 Résultats Financiers Conférence Téléphonique Portefeuille Innate Pharma Biotechnologies
PRESS RELEASE published on 09/10/2025 at 10:30, 10 months 3 days ago Inside Information / Other news releases Innate Pharma schedules conference call and webcast for first half 2025 financial results and business update. Details for participation available on the company's website Financial Results Conference Call Business Update Webcast Innate Pharma
BRIEF published on 09/02/2025 at 07:05, 10 months 12 days ago Innate Pharma : Mise à jour sur le capital et les droits de vote Droits De Vote Actions AMF Immobilier Innate Pharma
BRIEF published on 09/02/2025 at 07:05, 10 months 12 days ago Innate Pharma: Update on capital and voting rights Voting Rights Real Estate Actions AMF Innate Pharma
Published on 07/14/2026 at 01:45, 6 hours 32 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 8 hours 16 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 9 hours 7 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 10 hours 42 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 12 hours 17 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/14/2026 at 08:00, 17 minutes ago Coinsilium Group Limited: Predictive Labs Unveils Nijinn; Coinsilium Increases Strategic Investment and Accelerates Venture-Building Strategy
Published on 07/14/2026 at 07:47, 29 minutes ago EQS-Adhoc: DATA MODUL Aktiengesellschaft Produktion und Vertrieb von elektronischen Systemen:
Published on 07/14/2026 at 07:30, 47 minutes ago REINET INVESTMENTS S.C.A. SHARE BUYBACK PROGRAMME – UPDATE 14 July 2026
Published on 07/13/2026 at 18:00, 14 hours 17 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 14 hours 17 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 14 hours 17 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
